Y-Intercept (HK)’s Adaptive Biotechnologies ADPT Stock Holding History

Y-Intercept (HK)’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.9M	Buy	+135,137	New	+$2.07M	0.06%	495
2026 Q1	–	Sell	-23,777	Closed	-$386K	–	1507
2025 Q4	$386K	Buy	+23,777	New	+$388K	0.01%	1307
2024 Q3	–	Sell	-67,252	Closed	-$243K	–	1251
2024 Q2	$243K	Buy	+67,252	New	+$213K	0.01%	1103
2023 Q3	–	Sell	-18,310	Closed	-$123K	–	1010
2023 Q2	$123K	Sell	18,310 -8,816	-33%	-$65.6K	0.01%	1035
2023 Q1	$240K	Buy	+27,126	New	+$239K	0.03%	873
2022 Q2	–	Sell	-14,876	Closed	-$206K	–	832
2022 Q1	$206K	Buy	+14,876	New	+$234K	0.05%	605
2021 Q2	–	Sell	-8,040	Closed	-$302K	–	598
2021 Q1	$302K	Buy	8,040 +3,647	+83%	+$197K	0.08%	400
2020 Q4	$261K	Buy	+4,393	New	+$227K	0.11%	360

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Y-Intercept (HK)'s ADPT Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in Adaptive Biotechnologies (ADPT) in Q2 2026: 135,137 shares worth $2.9M. The stake represents 0.06% of the portfolio and ranks #495 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in ADPT as recently as Q4 2025.

Y-Intercept (HK) first reported a position in ADPT in Q4 2020 and has held it in 8 quarters since. 301 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

Y-Intercept (HK) held 135,137 shares of Adaptive Biotechnologies worth $2.9M as of Q2 2026.
Adaptive Biotechnologies was a new Y-Intercept (HK) position in Q2 2026.
Adaptive Biotechnologies made up 0.06% of Y-Intercept (HK)'s portfolio in Q2 2026, its #495 holding.
Y-Intercept (HK) first reported a position in Adaptive Biotechnologies in Q4 2020 and has held it in 8 quarters since.
301 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.